Fact CheckerSign in

NCT06170385Completed

Pediatric Early Rehabilitation in Acute Lymphoblastic Leukemia

Pediatric Early Rehabilitation in ACute Lymphoblastic LEukemia (PEACE): A Feasibility Study of a Hybrid Delivery Format

Source: ClinicalTrials.gov · Last updated 6 Feb 2026

Brief summary (registry, in English)

The purpose of this study is to determine the feasibility and acceptability of a hybrid in-person and virtual individualized physiotherapy program using the Healthy Eating and Active Living (HEAL-ME) online platform for children diagnosed with acute lymphoblastic leukemia. We would like to know if this type of hybrid program delivery model is feasible, and if children and their parents are willing and able to participate in the program. We will do this by recording how many, and what type of physiotherapy sessions (in-person or virtual) are completed, what resources offered on the platform are accessed, and how many children complete the assessments.

Status (registry)
Completed
Study type
Interventional
Enrollment
10 (actual)
First submitted
6 Dec 2023
Start date
15 Apr 2024
Primary completion date
31 Dec 2025
Lead sponsor
University of Alberta
NCT number
NCT06170385

What you commit to

  • Study type: Interventional
  • Participants enrolled: 10
  • From 15 Apr 2024 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Children with a history of a neurodevelopmental or genetic disorder (i.e., Down syndrome, autism, seizure disorder) prior to the cancer diagnosis; and
  • Children with a concurrent condition (illness, disease, psychiatric disorder), as determined by oncologist or physiotherapist, that would compromise study participation or interpretation of study results.

Who the study is looking for

  • Children diagnosed with acute lymphoblastic leukemia aged between 4 and 17 years (at time of diagnosis) and their mother, father, or primary carer;
  • Undergoing or completed cancer treatment as established by the Children's Oncology Group;
  • Access to the internet through a home computer or tablet;
  • Patient or caregiver is able to speak and comprehend English; and
  • The child is approved by their Oncologist to participate in the program.

Age in the registry: 4 years to 17 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Alberta
Coordinator of this site? Confirm its status
EdmontonCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.